Breadcrumb Home Media centre Media releases Media Releases Quick Explore In the news Featured Stories Cipla acquires novel anti-infective Elores to further anti- microbial stewardship in critical care in India Breathe Free Lanka partners with Novartis in Sri Lanka to provide Ultibro® Breezhaler® Alvotech and Cipla Gulf enter into a partnership for the Commercialization of key biosimilar in select emerging markets Cipla USA furthers AMR stewardship with acquisition of key anti-infective ZEMDRI™ (IV Plazomicin) Year 201920182017201620152014201320122010 Search News Apply Media Releases 2019 Cipla acquires novel anti-infective Elores to further anti- microbial stewardship in critical care in India Breathe Free Lanka partners with Novartis in Sri Lanka to provide Ultibro® Breezhaler® Alvotech and Cipla Gulf enter into a partnership for the Commercialization of key biosimilar in select emerging markets Cipla USA furthers AMR stewardship with acquisition of key anti-infective ZEMDRI™ (IV Plazomicin) InvaGen (a Cipla subsidiary) receives final approval for generic version of Pfizer’s Lyrica® (Pregabalin Capsules, 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg) Cipla receives final approval for generic version of Gilead Sciences, Inc’s Letairis® (Ambrisentan Tabs, 5mg & 10mg) Cipla appoints Dr. Raju Mistry as Global Chief People Officer CIPLA MEDPRO ACQUIRES A STAKE IN CONNECTED HEALTH COMPANY BRANDMED Cipla Technologies LLC and Pulmatrix enter into Definitive Agreement for the Development and Commercialization of Pulmazole Cipla launches Niveoli™, India’s first extrafine ICS-LABA combination HFA inhaler Cipla and Wellthy Therapeutics Announce Partnership to offer Digital Therapeutics for Diabetes and Cardiovascular Diseases Cipla receives final approval for generic version of Eli Lilly & Co.’s Adcirca® (Tadalafil Tablets 20mg) Cipla receives final approval for generic version of Pfizer’s Depo-Provera® (Medroxyprogesterone Injectable, 150mg/mL)
